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To the Editors
The presacral region has unique anatomic and oncologic
properties. It is occupied by loose connective tissue,
nerves, blood, and lymphatic vessels [6]. Syed et al. [6]
analyzed the histological diagnosis of 91 cases with sacral/
presacral mass lesions after biopsy. Lesions were pre-
dominantly neoplastic (70%) with metastases and second-
ary tumors (77%, plasma cell tumor, colorectal carcinoma,
lymphoma, breast carcinoma, to name the most common)
outbalancing primary neoplasms (23%). The nonneoplastic
lesions were preferentially inflammatory. The variety of
mass lesions in the presacral space underlines that a his-
tological analysis is essential to make the adequate therapy
decision.
Minimally invasive biopsy of presacral mass lesions can
be performed along different trajectories. The most com-
mon approaches are anterior or lateral transabdominal,
transgluteal through the greater sciatic foramen, and
anterolateral extraperitoneal [1, 2]; however, alternative
approaches, such as transosseous (transsacral or transiliac)
[2, 3], precoccygeal [7], and endoscopically perineal [5],
have been described. Nevertheless, lesions in the upper
presacral space especially close to the os sacrum can be
challenging to acquire histologic samples. In this context,
we describe a sacral, transneuroforaminal approach. To our
knowledge, this is the first report of obtaining a biopsy
sample of a presacral lesion through this access. To mini-
mize the risk of complications, we applied a computed
tomography-based navigation system for procedure
guidance.
Case Report
A 62-year-old woman was referred to our department with
a 5-year history of malignant melanoma of the upper back.
Annual positron-emission tomography/computed tomog-
raphy (PET–CT) control using a combined PET–CT
scanner (GE Medical Systems, General Electric Company,
Fairfield, CT, US) revealed a fluor-deoxy-glucose (FDG)-
positive mass lesion in the upper presacral space. In light of
the patient history, biopsy was immediately performed.
Vulnerable structures, such as the sciatic nerve, the internal
iliac artery, and the sigmoid colon along a caudocranial
needle path, precluded a transgluteal approach through the
greater sciatic foramen. Because the suspicious mass lesion
was located immediately ventral to the right S1-neurofo-
ramen, a transforaminal approach was chosen.
Percutaneous CT-guided intervention was performed in
a 64-slice CT-scanner (Somatom Sensation 64, Siemens
Medical Solutions, Erlangen, Germany) using a navigation
system for percutaneous interventions (ActiViews, Haifa,
Israel). The patient was positioned prone with arms fixed
above his head. Conscious sedation (Midazolam/Dormi-
cum and Alfentanil/Rapifen) was administered intrave-
nously, and vital parameters were continuously monitored.
For procedure planning, noncontrast CT of the pelvis was
performed. By means of an X-ray-absorbing grid on the
skin, the cutaneous entry point was chosen. A single-use
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reference pad with CT-visible fiducial markers was
attached to the patient’s skin. A navigation CT scan
without contrast media was then performed and data were
transferred to the navigation system, where the needle
trajectory was planned. The cutis was locally anesthetized
with 9 ml of mepivacaine 1.5% diluted with 1 ml of
natrium bicarbonate 8.4%. Along the prior planned tra-
jectory and according to its lengths, a 17G 14.3 cm coaxial
introducer needle (Medical Device Technologies Inc.,
Gainesville, FL) was chosen. A miniature, single-use video
camera was then attached to the needle (Fig. 1). During
navigation, the mapping of the camera and the probe are
determined relative to the fiducial markers. The combina-
tion of the above mapping enables determination of the
needle position relative to the actual target. The needle was
then advanced in a single step to the dorsal ostium of the
S1 neuroforamen (Fig. 2A). Before entering the S1 neu-
roforamen, the periosteum was locally anesthetized; how-
ever, only 2 ml of bupivacaine 0.25% was administered to
avoid nerve root block. After a low-dose CT control (slice
thickness 3 mm), the needle was slowly advanced through
the neuroforamen without needing to correct the trajectory.
During this procedure, the patient negated any radicular
pain sensation. A further CT control showed correct
placement of the needle tip at the target lesion. After
removal of the inner stylet, an 18G 20-cm Menghini-type
semiautomatic biopsy device (Biomol, H.S. Hospital Ser-
vice, Rome, Italy) was inserted for biopsy. Five biopsy
specimens were taken from different portions of the lesion
by a slight movement of the coaxial needle tip in left–right
and cranio–caudal directions (Fig. 2B, C). The solid
specimens were deposited in a fixating solution and sent for
histopathological analysis. The procedure lasted 53 min
from the initial CT planning to the postinterventional
control. The follow-up CT showed no signs of complica-
tions. The patient tolerated the procedure well and was
monitored for an additional 6 h after the procedure without
evidence of S1-palsy, paresthesia, or other complications.
The combined morphologic and immunohistochemical
diagnosis was that of a soft-tissue metastasis of the previ-
ously diagnosed malignant melanoma.
Discussion
The cytological and histological assessment of suspicious
mass lesions is mandatory to allow potential tumor staging
and therapy planning. Small lesions in the upper presacral
space can be challenging for needle biopsy, because they
are difficult to impossible to reach via a caudal or lateral
approach. In those cases, and if in the effective direction, a
transneuroforaminal approach is an alternative. The sacral
transneuroforaminal approach is a common technique for
electrical nerve stimulation for bladder dysfunction or
Fig. 1 Setup of the applied, CT-based navigation system. The
fiducial markers on the reference pad on the patient’s skin are
captured by the miniature camera attached to the needle
Fig. 2 A CT control after carefully advancing the needle through the
S1- neuroforamen after application of a minimal amount of local
anesthesia at the dorsal ostium to avoid nerve root block. To obtain
the biopsy specimen, the needle tip was slightly moved in lateral and
cranio-caudal directions (B, C)
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chronic pain management [4]; however, needle diameter is
significantly less than that necessary to obtain biopsy
specimen. The utilized 17-gauge (1.4 mm) coaxial needle
is still small compared with the S1 neuroforamen. We
measured 8.5 mm as the minimal diameter of the ventral
ostium where the S1-nerve root leaves and 5.8 mm for the
dorsal ostium, where only minor sensory skin branches
leave. A navigation system for CT-guided biopsies ensures
that the needle exactly follows the planned trajectory,
especially in off-axial approaches. Therefore, the use of a
navigation system minimizes the risk of injuring the nerve
root due to intraforaminal correction of the needle path or
reposition of the needle. To avoid nerve root injury while
passing intraforaminally, we administered only a small
amount of local anesthetic at the dorsal ostium of the
neuroforamen to anesthetize the periosteum and still have
patient feedback regarding pain or sensomotory sensations.
The costs of the applied system are $75,000 USD, which
includes training, service, and disposables for a year.
Subsequent disposables amount to $300 per procedure.
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